Bronchiectasis is a complex and heterogeneous disease with a myriad of pulmonary and
extrapulmonary etiologies. Bronchiectasis has a predominantly neutrophilic inflammatory …

Background. Dupilumab represents the first approved biological for severe uncontrolled
chronic rhinosinusitis with nasal polyps (CRSwNP). Objective. Aim of this paper is to provide …

Various chronic inflammatory airway diseases can be treated with low-dose, long-term
(LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for …

Introduction: Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disease
with multifactorial etiopathogenesis. This study investigated the recurrence rate and risk …

Chronic rhinosinusitis (CRS) is characterized by sinonasal mucosal inflammation.
Staphylococcus aureus (S. aureus) is associated with severe CRS phenotypes. Different …

Purpose Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) is a chronic sinonasal
inflammatory disease characterized histologically by hyperplastic nasal epithelium and …

Chronic rhinosinusitis (CRS) is one of the most common conditions all over the world. The
purpose of this study was to investigate the effects of low-level laser therapy (LLLT) in …

Background: The introduction of biological drugs in the management of chronic
rhinosinusitis with nasal polyps (CRSwNP) is allowing new and increasingly promising …

Chronic rhinosinusitis is defined as a complex of disorders whose main feature is nasal and
paranasal sinus mucosal inflammation for at least three months. Inflammation plays a key …

Objective To investigate the correlation between chronic rhinosinusitis (CRS) and bronchial
asthma, focusing on the CRS without nasal polyps (CRSsNP) and CRS with nasal polyps …